1. Home
  2. CNDT vs BCYC Comparison

CNDT vs BCYC Comparison

Compare CNDT & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Conduent Incorporated

CNDT

Conduent Incorporated

HOLD

Current Price

$1.94

Market Cap

448.6M

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$7.16

Market Cap

476.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNDT
BCYC
Founded
2016
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
448.6M
476.6M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CNDT
BCYC
Price
$1.94
$7.16
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$18.73
AVG Volume (30 Days)
1.2M
272.8K
Earning Date
11-07-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,072,000,000.00
$28,339,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.37
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.72
$6.03
52 Week High
$4.90
$15.47

Technical Indicators

Market Signals
Indicator
CNDT
BCYC
Relative Strength Index (RSI) 43.20 50.84
Support Level $1.97 $6.73
Resistance Level $2.08 $7.50
Average True Range (ATR) 0.10 0.37
MACD 0.02 -0.01
Stochastic Oscillator 29.18 46.74

Price Performance

Historical Comparison
CNDT
BCYC

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: